Synapse - Paul J Balderes

Paul J Balderes

Research Focus

Strategy and Innovation; Associate Director, Drug Development

Recent additions – View all

ROS-activatable prodrug of doxazolidine as novel cancer therapy paradigm
Journal Article

Tamura, R.; Carpenter, C. I.; Thomas, C. M.; Kamyabi, G.; Hsu, H. T.; Vergnolle, O.; Balderes, P.; Grimm, J.
Advanced Therapeutics (2024)

Fulltext@MSK | Save
(89)Zr-immunoPET-guided selection of a CD33xIL15 fusion protein optimized for antitumor immune cell activation and in vivo tumour retention in acute myeloid leukaemia
Journal Article

Herrero Alvarez, N.; Molvi, Z.; Lupo, K.; Urraca, J.; Balderes, P.; Nyakatura, E. K.; Khan, A. G.; Viray, T.; Lewis, J. S.; O’Reilly, R. J.
European Journal of Nuclear Medicine and Molecular Imaging (2024)

Fulltext@MSK | Save
(89)Z-immuno-PET guided preclinical development of targeted therapies: Demonstrating utility by evaluating fusion proteins in vivo
Meeting Abstract

Herrero Alvarez, N.; Lewis, J.; Molvi, Z.; O'Reilly, R.; Nyakatura, E.; Balderes, P.; Viray, T.
Nuclear Medicine and Biology (2022)

Fulltext@MSK | Save

Co-authors at MSK

3

Molvi
3

Nyakatura
3

O'Reilly
2

Herrero...
2

Khan
2

Lewis
2

Viray
1

Carpenter
1

Dao
1

Grimm
1

Hsu
1

Kamyabi
1

Korontsvit
1

Lorenz
1

Lupo
1

Mun
1

Pohl
1

Scheinberg
1

Tamura
1

Thomas
1

Urraca
1

Vergnolle
1

White

Types of Work

Publications

Advanced Therapeutics (1)
European Journal of Nuclear Medicine and Molecular Imaging (1)
JCI Insight (1)
Nuclear Medicine and Biology (1)